Tanvex BioPharma, Inc. (TPE: 6541)
Taiwan
· Delayed Price · Currency is TWD 68.50
+3.40 (5.22%)
Jan 20, 2025, 1:30 PM CST
Tanvex BioPharma Revenue
Tanvex BioPharma had revenue of 11.50M TWD in the quarter ending September 30, 2024, with 125.33% growth. This brings the company's revenue in the last twelve months to 40.96M, down -32.00% year-over-year. In the year 2023, Tanvex BioPharma had annual revenue of 61.41M with 174.11% growth.
Revenue (ttm)
40.96M
Revenue Growth
-32.00%
P/S Ratio
249.91
Revenue / Employee
294.64K
Employees
139
Market Cap
11.37B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Caliway Biopharmaceuticals | 49.98M |
| Bora Pharmaceuticals Co., LTD. | 16.71B |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Center Laboratories | 1.57B |